Cholamandalam Investment and Finance Company (511243) Q4 21/22 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 21/22 earnings summary
16 Oct, 2026Executive summary
Q4 FY22 delivered record disbursements, collections and profitability, supported by recovery in auto and mortgage markets; AUM reached ₹82,904 Cr, up 8% YoY.
FY22 PAT rose 42% YoY to ₹2,147 Cr; Q4 PAT increased 184% YoY to ₹690 Cr.
Financial highlights
Total income was ₹2,632 Cr in Q4 FY22 and ₹10,139 Cr in FY22; FY PBT was ₹2,891 Cr, up 42% YoY.
FY22 PAT was ₹2,147 Cr versus ₹1,515 Cr; Q4 PAT was ₹690 Cr versus ₹243 Cr in Q4 FY21.
FY22 disbursements reached ₹35,490 Cr, up 36% YoY; Q4 disbursements of ₹12,718 Cr rose 58% YoY.
FY22 loan losses were ₹880 Cr versus ₹1,378 Cr; Q4 loan losses were a net credit of ₹17 Cr versus ₹520 Cr expense in Q4 FY21.
Segment performance
Vehicle Finance FY22 disbursements were ₹25,439 Cr, up 26% YoY; Q4 disbursements rose 43% to ₹8,785 Cr.
Loan Against Property FY22 disbursements rose 62% to ₹5,862 Cr; Home Loan disbursements were ₹1,571 Cr versus ₹1,542 Cr.
New CSEL, SBPL and SME lending disbursed ₹2,619 Cr in FY22, up 319% YoY; Q4 disbursements rose 702% to ₹1,515 Cr.
Standalone FY22 segment revenue: Vehicle Finance ₹7,57,837 lakh, LAP ₹1,61,349 lakh and Home Loans ₹60,043 lakh; corresponding PBT was ₹1,99,928 lakh, ₹40,865 lakh and ₹18,945 lakh.
Latest events from Cholamandalam Investment and Finance Company
- Q2 disbursements rose 47%, PAT 41%, and a QIP of up to ₹5,000 crore was approved.511243
Q2 26/27 - Robust financials, a forceful rebuttal and improving Q3 disbursement momentum.511243
Status update - PPOP grew 56%, but pandemic-driven loan losses cut Q1 PAT 24%.511243
Q1 21/22 - Strong Q2 growth and improving asset quality, with COVID-related credit risk still elevated.511243
Q2 21/22 - Disbursements jumped 267% and PAT grew 73%, with Stage 3 improving to 4.16%.511243
Q1 22/23 - Record disbursements and AUM growth offset a tougher Q2 PAT comparison.511243
Q2 22/23 - Q3 disbursements +68%, AUM +31% and standalone PAT +31% YoY.511243
Q3 22/23 - Disbursements surged 50% as higher funding costs tempered Q1 profit growth.511243
Q1 23/24 - Record FY23 lending growth and improved asset quality supported higher profit.511243
Q4 22/23